Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 4Completed 2Withdrawn 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 33Breast Neoplasms 25Colorectal Neoplasms 20Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Brain Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Lung Neoplasms 6Colonic Neoplasms 6Pain 5Depression 5Carcinoma, Hepatocellular 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Motor Activity 4Inflammation 4Head and Neck Neoplasms 4Epilepsy 4Dementia 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Lymphoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Neoplasms, Glandular and Epithelial × Clear all
NCT04755517 2025-01-13

HPV400

Tampere University Hospital

Phase NA Enrolling by invitation
14,000 enrolled
Gynecologic

Carcinoma, Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Adenocarcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡